[1] |
| Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment? |
|---|
| Authors : Lahtela Heli H; Karjalainen Pasi P PP; Niemelä Matti M; Vikman Saila S; Kervinen Kari K; Ylitalo Antti A; Puurunen Marja M; Porela Pekka P; Nyman Kai K; Hinkka-Yli-Salomäki Susanna S; Airaksinen K E Juhani KE; |
| Affiliation : Department of Medicine, Turku University Hospital, Turku, Finland. |
| Journal : Thromb. Haemost. (2009) |
| Related Links: Pubmed | Publisher website |
| Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting. |
| Authors : Lip Gregory Y H GY; Huber Kurt K; Andreotti Felicita F; Arnesen Harald H; Airaksinen K Juhani KJ; Cuisset Thomas T; Kirchhof Paulus P; Marín Francisco F; ; |
| Affiliation : University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, B18 7QH, United Kingdom. g.y.h.lip@bham.ac.uk |
| Journal : Thromb. Haemost. (2010) |
| Related Links: Pubmed | Publisher website |
| Altered Complexity and Correlation Properties of R-R Interval Dynamics Before the Spontaneous Onset of Paroxysmal Atrial Fibrillation |
| Authors : Vikman S; Mäkikallio TH; Yli-Mäyry S; Pikkujämsä S; Koivisto AM; Reinikainen P; Airaksinen KE; Huikuri HV; |
| Affiliation : Division of Cardiology, Department of Medicine, the Tampere School of Public Health, University of Tampere, Finland. saila.vikman@koti.tpo.fi |
| Journal : Circulation (2011) |
| Related Links: Pubmed | Publisher website |

